Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
VIDEO
Propanc Biopharma Is Readied for Revolutionary Cancer Treatment, CEO Says
By Kinsey Grant
Dec 5, 2017 7:49 PM EST
PRESS RELEASES
Propanc Biopharma Receives Expression Of Interest To Evaluate Proenzyme Therapy In Pancreatic And Ovarian Cancer Patients
By Business Wire
Jan 18, 2021 8:30 AM EST
PRESS RELEASES
Propanc Biopharma Advances POP1 Joint Research And Drug Discovery Program For Projected US$111.2B Global Metastatic Cancer Market
By Business Wire
Dec 30, 2020 8:30 AM EST
PRESS RELEASES
Propanc Biopharma Receives Investment From Institutional Investor
By Business Wire
Jul 28, 2020 8:30 AM EDT
PRESS RELEASES
Propanc Biopharma Provides Shareholder Update
By Business Wire
May 11, 2020 8:30 AM EDT
PRESS RELEASES
How Propanc Biopharma Is Joining The Fight With Cancer Patients Who Are Increasingly Vulnerable To The COVID-19 Global Pandemic
By Business Wire
Apr 16, 2020 8:30 AM EDT
PRESS RELEASES
Propanc Biopharma Receives First Allowance For Key Patent Family From Australian Patent Office
By Business Wire
Apr 14, 2020 9:00 AM EDT
PRESS RELEASES
Propanc Biopharma Enters Into A $3 Million Financing With Institutional Investor
By Business Wire
Mar 31, 2020 9:00 AM EDT
PRESS RELEASES
Professor Macarena Perán (Photo: Business Wire)
By Business Wire
Mar 16, 2020 8:30 AM EDT
VIDEO
Propanc Biopharma Is Readied for Revolutionary Cancer Treatment, CEO Says
By Kinsey Grant
Dec 5, 2017 7:49 PM EST
